Nalaganje...
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
BACKGROUND/AIMS: Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease (NAFLD) characterized by hepatic steatosis, inflammation, hepatocellular injury, and fibrosis. We aimed to investigate the usefulness of a key biomarker, lipocalin-2 (LCN2), for the detecti...
Shranjeno v:
| izdano v: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Korean Association for the Study of the Liver
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8046622/ https://ncbi.nlm.nih.gov/pubmed/33465844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0261 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|